News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Debasish Tripathy

Articles by Debasish Tripathy

TPS 24 Phase Ib Dose-Finding Study of [177Lu]Lu-NeoB + Ribociclib + Fulvestrant in Patients With ER+/HER2− Advanced Breast Cancer With GRPR Expression With Early Relapse FromAdjuvant Endocrine Therapy or Progression on ET + CDK4/6i for ABC

ByDebasish Tripathy,Dejan Juric,Sonia Pernas,Francois Clement Bidard,Kevin Perraud,Louise Emmett,Ana Sofia Ferreira

June 22nd 2025

TPS 25 Phase 1/2 Study of the Novel Radioligand Therapy [177Lu]Lu-NeoB Plus Capecitabine in Patients With ER+/HER2− Advanced Breast Cancer (ABC) With GRPR Expression After Progression on Prior Endocrine Therapy Plus a CDK4/6 Inhibitor for ABC

ByMario Campone,Louise Emmett,Dejan Juric,Debasish Tripathy,Sonia Pernas,Monica Zuradelli,Kevin Perraud,Aleix Prat

June 21st 2025

Latest Updated Articles

Trending on CancerNetwork

Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer

Toxicity From CD19, BCMA Therapy May Inform B-Cell Malignancy Surveillance

FDA Approves T-DXd in 2 Indications for HER2+ Early Breast Cancer

Frontline Sevabertinib Earns FDA Priority Review in HER2-Mutated NSCLC

Nogapendekin Alfa Plus BCG Exhibits Efficacy Advantage in NMIBC In Situ